The ankyrin repeat protein Diversin recruits Casein kinase Iε to the β-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signaling

  1. Thomas Schwarz-Romond1,
  2. Christian Asbrand1,
  3. Jeroen Bakkers2,
  4. Michael Kühl3,
  5. Hans-Joerg Schaeffer1,
  6. Jörg Huelsken1,
  7. Jürgen Behrens4,
  8. Matthias Hammerschmidt2, and
  9. Walter Birchmeier1,5
  1. 1Max Delbrueck-Center for Molecular Medicine, D-13092 Berlin, Germany; 2Max Planck Institute for Immunobiology, D-79108 Freiburg, Germany; 3University of Ulm, Department of Biochemistry, D-89081 Ulm, Germany; 4University of Erlangen, Nikolaus-Fiebiger-Center, D-91054 Erlangen, Germany

Abstract

Wnt signals control decisive steps in development and can induce the formation of tumors. Canonical Wnt signals control the formation of the embryonic axis, and are mediated by stabilization and interaction of β-catenin with Lef/Tcf transcription factors. An alternative branch of the Wnt pathway uses JNK to establish planar cell polarity inDrosophila and gastrulation movements in vertebrates. We describe here the vertebrate protein Diversin that interacts with two components of the canonical Wnt pathway, Casein kinase Iε (CKIε) and Axin/Conductin. Diversin recruits CKIε to the β-catenin degradation complex that consists of Axin/Conductin and GSK3β and allows efficient phosphorylation of β-catenin, thereby inhibiting β-catenin/Tcf signals. Morpholino-based gene ablation in zebrafish shows that Diversin is crucial for axis formation, which depends on β-catenin signaling. Diversin is also involved in JNK activation and gastrulation movements in zebrafish. Diversin is distantly related to Diego of Drosophila, which functions only in the pathway that controls planar cell polarity. Our data show that Diversin is an essential component of the Wnt-signaling pathway and acts as a molecular switch, which suppresses Wnt signals mediated by the canonical β-catenin pathway and stimulates signaling via JNK.

Keywords

Footnotes

  • 5 Corresponding author.

  • E-MAIL wbirch{at}mdc-berlin.de; FAX 49-30-94-062-656.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.230402.

    • Received March 11, 2002.
    • Accepted June 12, 2002.
| Table of Contents

Life Science Alliance